Salarius Pharmaceuticals, Inc. (SLRX)
0.6488
0.00 (0.00%)
USD |
NASDAQ |
Dec 31, 16:00
0.642
-0.01
(-1.05%)
After-Hours: 20:00
Salarius Pharmaceuticals EPS Diluted (Quarterly): -1.814 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| CorMedix, Inc. | 1.259 |
| Outset Medical, Inc. | -1.003 |
| Vor Biopharma, Inc. | -121.63 |
| Humacyte, Inc. | -0.1106 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.8735M |
| Total Expenses (Quarterly) | 0.8735M |
| Enterprise Value | -4.479M |
| Earnings Yield | -3.83K% |
| Normalized Earnings Yield | -3829.55 |